A detailed history of Clough Capital Partners L P transactions in Argenx Se stock. As of the latest transaction made, Clough Capital Partners L P holds 895 shares of ARGX stock, worth $562,346. This represents 0.05% of its overall portfolio holdings.

Number of Shares
895
Previous 895 -0.0%
Holding current value
$562,346
Previous $384,000 26.3%
% of portfolio
0.05%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$356.95 - $413.29 $4.14 Million - $4.79 Million
-11,596 Reduced 92.83%
895 $352,000
Q4 2023

Feb 14, 2024

SELL
$338.91 - $506.01 $1.71 Million - $2.56 Million
-5,059 Reduced 28.83%
12,491 $4.75 Million
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $6.48 Million - $9.62 Million
17,550 New
17,550 $8.63 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.